Publication | Closed Access

Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation

RheumatologyAutoimmune DiseaseRuxolitinib TreatmentSteroid-dependent Severe AutoimmunityLupusImmunologyAutoimmunityStat1 Gain-of-function MutationMedicineRheumatoid Arthritis